eMed, LLC

eMed, LLC, founded in 2020, is a telehealth company that provides employer-sponsored preemptive health management. Its platform combines digital health services and clinical oversight with care delivered to patients' homes, drawing on technical domains including telehealth, virtual care, remote patient monitoring, at-home diagnostics and preventive health management.

The company's product set comprises the eMed telehealth platform, which offers continuous virtual care and personalised support; a clinically guided GLP-1 weight loss programme that pairs FDA-approved medications, such as Wegovy and Ozempic, with at-home blood testing and ongoing virtual care; and at-home blood testing integrated with virtual clinical care. eMed describes itself as the leading platform for employer-sponsored preemptive health management and serves verticals spanning healthcare, digital health, weight management, preventive care, employer benefits, health insurance and payers, and government and public health.

Named leadership includes former X CEO Linda Yaccarino and Chief Wellness Officer Tom Brady. The company states a mission-driven focus on improving population health and on responsible access to proven GLP-1 treatments, with a home-centred care model oriented around patient convenience.